These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32762073)

  • 21. Novel substituted pyrazolone derivatives as AMP-activated protein kinase activators to inhibit lipid synthesis and reduce lipid accumulation in ob/ob mice.
    Zhang M; Xie ZF; Zhang RT; Chen DK; Gu M; Cui SC; Zhang YM; Zhang XW; Yu YY; Li J; Nan FJ; Li JY
    Acta Pharmacol Sin; 2018 Oct; 39(10):1622-1632. PubMed ID: 29795358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A crystallized view of AMPK activation.
    Young LH
    Cell Metab; 2009 Jul; 10(1):5-6. PubMed ID: 19583947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidiabetic and antiobesity effects of Ampkinone (6f), a novel small molecule activator of AMP-activated protein kinase.
    Oh S; Kim SJ; Hwang JH; Lee HY; Ryu MJ; Park J; Kim SJ; Jo YS; Kim YK; Lee CH; Kweon KR; Shong M; Park SB
    J Med Chem; 2010 Oct; 53(20):7405-13. PubMed ID: 20873794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and biochemical insights into the allosteric activation mechanism of AMP-activated protein kinase.
    Li J; Li S; Wang F; Xin F
    Chem Biol Drug Des; 2017 May; 89(5):663-669. PubMed ID: 27809416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential AMPK activators of cucurbitane triterpenoids from Siraitia grosvenorii Swingle.
    Chen XB; Zhuang JJ; Liu JH; Lei M; Ma L; Chen J; Shen X; Hu LH
    Bioorg Med Chem; 2011 Oct; 19(19):5776-81. PubMed ID: 21893415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
    Alam MS; Lee DU
    Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promise and challenges for direct small molecule AMPK activators.
    Olivier S; Foretz M; Viollet B
    Biochem Pharmacol; 2018 Jul; 153():147-158. PubMed ID: 29408352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy.
    Gupta AK; Bharadwaj M; Kumar A; Mehrotra R
    Top Curr Chem (Cham); 2017 Feb; 375(1):3. PubMed ID: 27943171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.
    Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH
    Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA-dependent protein kinase regulates lysosomal AMP-dependent protein kinase activation and autophagy.
    Puustinen P; Keldsbo A; Corcelle-Termeau E; Ngoei K; Sønder SL; Farkas T; Kaae Andersen K; Oakhill JS; Jäättelä M
    Autophagy; 2020 Oct; 16(10):1871-1888. PubMed ID: 31983282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biophysical Interactions of Direct AMPK Activators.
    Kurumbail RG; West GM; Dharmarajan V; Borzilleri KA; Withka JM; Ward J; Reyes AR; Rajamohan F; Griffin PR; Calabrese MF
    Methods Mol Biol; 2018; 1732():29-55. PubMed ID: 29480467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene of the month. AMP kinase (PRKAA1).
    Krishan S; Richardson DR; Sahni S
    J Clin Pathol; 2014 Sep; 67(9):758-63. PubMed ID: 24895169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics.
    Arkwright RT; Deshmukh R; Adapa N; Stevens R; Zonder E; Zhang Z; Farshi P; Ahmed RS; El-Banna HA; Chan TH; Dou QP
    Anticancer Agents Med Chem; 2015; 15(5):657-71. PubMed ID: 25511514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and Physiological Regulation of AMPK.
    Yan Y; Zhou XE; Xu HE; Melcher K
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Mechanism of Nucleotide-Dependent Allosteric Regulation in AMP-Activated Protein Kinase.
    Ahalawat N; Murarka RK
    J Phys Chem B; 2017 Apr; 121(14):2919-2930. PubMed ID: 28345916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric Modulation of AMPK Enzymatic Activity: In Vitro Characterization.
    Ward J; Reyes AR; Kurumbail RG
    Methods Enzymol; 2017; 587():481-509. PubMed ID: 28253974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oestrogen receptors interact with the α-catalytic subunit of AMP-activated protein kinase.
    Lipovka Y; Chen H; Vagner J; Price TJ; Tsao TS; Konhilas JP
    Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26374855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice.
    Li YY; Yu LF; Zhang LN; Qiu BY; Su MB; Wu F; Chen DK; Pang T; Gu M; Zhang W; Ma WP; Jiang HW; Li JY; Nan FJ; Li J
    Toxicol Appl Pharmacol; 2013 Dec; 273(2):325-34. PubMed ID: 24055643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-[2-(4-(trifluoromethyl)phenylamino)thiazol-4-yl]acetic acid (Activator-3) is a potent activator of AMPK.
    Bung N; Surepalli S; Seshadri S; Patel S; Peddasomayajula S; Kummari LK; Kumar ST; Babu PP; Parsa KVL; Poondra RR; Bulusu G; Misra P
    Sci Rep; 2018 Jun; 8(1):9599. PubMed ID: 29942003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.